By using the advantage of hybrid nanomaterials, researchers may have unlocked a new pharmacological route for treating degenerative diseases.
Sarah Barron
Sarah has a multidisciplinary background, completing her B.Sc. and M.Sci. in Neuroscience at Nottingham University before transferring into the Engineering field and completing her MRes in Sensor Technologies at Cambridge University. Sarah is currently pursuing her Ph.D. in Bioelectronics and Biotechnology at the University of Cambridge, where her focus lies in developing microelectronic devices to monitor epithelial barrier function in vitro. As well as her research, Sarah is equally as passionate about STEM outreach, scientific communication, and raising awareness for mental health causes.